Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| 1 |
Fidelity National Information Services
FIS
|
+$2.41B |
| 2 |
Mastercard
MA
|
+$1.77B |
| 3 |
Comcast
CMCSA
|
+$1.05B |
| 4 |
Honeywell
HON
|
+$911M |
| 5 |
Carrier Global
CARR
|
+$846M |
Top Sells
| 1 |
Amazon
AMZN
|
+$2.43B |
| 2 |
Deere & Co
DE
|
+$1.16B |
| 3 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$1.03B |
| 4 |
Humana
HUM
|
+$966M |
| 5 |
Microsoft
MSFT
|
+$759M |
Sector Composition
| 1 | Technology | 21.78% |
| 2 | Healthcare | 16.63% |
| 3 | Communication Services | 15.88% |
| 4 | Financials | 13.51% |
| 5 | Industrials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RVNC
351
DELISTED
Revance Therapeutics, Inc.
RVNC
| $29.2M | 0.01% |
1,161,900
| – | – |
|
352
Teradata
TDC
$2.03B
| $28.3M | 0.01% |
1,248,757
| – | – |
|
353
Graco
GGG
$14.1B
| $25.8M | 0.01% |
420,000
| – | – |
|
354
TopBuild
BLD
$11.6B
| $25.1M | 0.01% |
+147,000
| New | +$25.1M |
|
355
Lightspeed Commerce
LSPD
$1.67B
| $24.9M | 0.01% |
+777,695
| New | +$24.9M |
|
|
CLLS
356
Cellectis
CLLS
$311M
| $24.8M | 0.01% |
1,339,336
| – | – |
|
357
Grifois
GRFS
$6.81B
| $24.1M | 0.01% |
1,420,351
+82,561
| +6% | +$1.4M |
|
358
Cactus
WHD
$2.76B
| $24M | 0.01% |
1,249,900
| – | – |
|
359
Pool Corp
POOL
$12.2B
| $23.1M | 0.01% |
68,900
| – | – |
|
360
TotalEnergies
TTE
$135B
| $22.9M | 0.01% |
688,540
+193,594
| +39% | +$6.45M |
|
|
NCNA
361
NuCana
NCNA
$8.74M
| $22.8M | 0.01% |
883
+209
| +31% | +$5.41M |
|
362
Credicorp
BAP
$21.3B
| $22.7M | 0.01% |
183,425
-459,810
| -71% | -$57M |
|
363
Webster Financial
WBS
$9.87B
| $22.5M | 0.01% |
851,600
| – | – |
|
364
Yext
YEXT
$1.07B
| $22.1M | 0.01% |
1,454,400
| – | – |
|
|
SILK
365
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $21.5M | 0.01% |
320,600
| – | – |
|
366
Legend Biotech
LEGN
$6.37B
| $21.4M | 0.01% |
693,588
| – | – |
|
367
Sarepta Therapeutics
SRPT
$1.91B
| $21.3M | 0.01% |
151,623
| – | – |
|
|
AMTI
368
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $20.9M | 0.01% |
655,300
| – | – |
|
|
CMRC
369
Commerce.com, Inc. Series 1 Common Stock
CMRC
$385M
| $20.8M | 0.01% |
+250,000
| New | +$20.8M |
|
370
Fabrinet
FN
$12.7B
| $20.5M | 0.01% |
325,500
+107,420
| +49% | +$6.77M |
|
371
Petrobras
PBR
$83.2B
| $20.4M | 0.01% |
2,859,438
-6,681,999
| -70% | -$47.6M |
|
372
Endava
DAVA
$523M
| $20.3M | 0.01% |
322,200
| – | – |
|
373
Toll Brothers
TOL
$13.5B
| $19.9M | 0.01% |
+408,184
| New | +$19.9M |
|
|
AVLR
374
DELISTED
Avalara, Inc.
AVLR
| $19.2M | 0.01% |
150,683
+131,500
| +686% | +$16.7M |
|
|
CELL
375
DELISTED
PhenomeX Inc. Common Stock
CELL
| $19M | 0.01% |
+248,712
| New | +$19M |
|